Deciphera Pharmaceuticals Inc

+0.11 (+1.04%)
Earnings Announcements

Deciphera Pharmaceuticals Announces First Quarter 2022 Results

Published: 05/04/2022 13:04 GMT
Deciphera Pharmaceuticals Inc (DCPH) - Deciphera Pharmaceuticals, Inc. Announces First Quarter 2022 Financial Results.
Q1 Revenue $29.2 Million.
Deciphera Pharma - As of March 31, 2022, Cash, Cash Equivalents, &marketable Securities Were $275.4 Million, Compared to $327.6 Million As of Dec 31, 2021.
Deciphera-sees Current Cash, Cash Equivalents, & Marketable Securities, Anticipated Product, Royalty, & Supply Revenue to Fund Operating & Capex Into 2025.
Qtrly EPS $0.04.
Q1 Earnings per Share View $-0.90, Revenue View $26.4 Million -- Refinitiv Ibes Data (analyst estimates).
Revenue is expected to be $30.79 Million
Adjusted EPS is expected to be -$0.66

Next Quarter Revenue Guidance is expected to be $32.72 Million
Next Quarter EPS Guidance is expected to be -$0.62

More details on our Analysts Page.